Deal Announcements

Cempra Pharmaceuticals Clears $10 Million Financing

Tuesday, January 15, 2008 6:09:00 AM PDT | VentureDeal Staff

MORRISVILLE, NC -- Cempra Pharmaceuticals, Inc. said that it has received $10 million from strategic and existing venture capital investors.

Cempra is a biotech company focused on developing medicines to treat drug-resistant bacterial infections in the community and in hospitals.

Investors in the round were strategic investor Optimer Pharmaceuticals, Inc., and existing venture capital firms Aisling Capital and Intersouth Partners.  Proceeds purposes from the funding were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1